In addition, in UTUC, the use of MiR-26a-5p to inhibit WNT5A/β-catenin signaling affects the EMT process, significantly suppressing the cells’ invasion ability by downregulating the expression of NF-κB and MMP-9 [56]. The gene discussed is MMP9; the disease is renal pelvis/ureter urothelial carcinoma.